2025 Year In Review | Page 17

Ethan Henderson, 55, was diagnosed with Parkinson’ s in 2016.“ Three months ago, I was able to walk my dog, wash my car and mow the lawn. I would do anything— going in for infusions or injecting myself at home— to get back to that.”

New Dopamine Therapies Increase Treatment Options Infusions Gain Approval and Stem Cells Show Promise

While slowing the disease remains a primary research goal, it is critical that we drive the continued efforts to provide people with Parkinson’ s with more options to manage their wideranging symptoms.
Researchers continually look for ways to optimize dopamine therapies— the longstanding keystone treatment for managing PD motor symptoms like tremor, slowness and stiffness— to ensure they work for as long as possible as PD progresses. Since mid-2024, the FDA has approved three new dopamine-
14